Treatments for Abd pain, diarrhea, and constipation Flashcards

1
Q

Opioid agonists for diarrhea

A

Loperamide, dephenoxylate, eluxadoline

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Loperamide MOA

A

interferes with peristalsis and slows transit time, acts directly on circular and longitudinal muscles

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Side effects of loperamide

A

anticholinergic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Diphenoxylate MOA

A

inhibits GI motility and slows excess GI propulsion

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Side effects of diphenoxylate

A

anticholinergic

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Eluxadoline MOA

A

agonist at mu and kappa receptors in GI (slows peristalsis), antagonist at delta opioid receptors (decrease GI secretions)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Indications for eluxadoline

A

irritable bowel syndrome, diarrhea-precominant subtyoe

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Side effects eluxadoline

A

hepatic/pancreatic toxicity (increased enzymes), CNS-related (sedation, euphoria)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Contraindications eluxadoline

A

biliary duct obstruction, alcoholism, history of pancreatitis, severe hepatic impairment

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Alosetron MOA

A

selectively blockd GI-based 5HT3 receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

Indications for Alosetron

A

chronic, severe IBS-D not responsive to other therapies

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Side effects alosetron

A

GI-related, ischemic cholitis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Ischemic colitis (Black Box Warning)

A

physicians must enroll in a prescribing program, patients and physicians must sign a risk-benefit statement, additional training by physicians required, follow up for refills

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Alosetron contraindications

A

GI obstruction, perforation, stricture, toxic mega colon, diverticulitis, IBD, impaired intestinal circulation, severe constipation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Crofelemer MOA

A

inhibits Cl ion secretion by blocking cAMP-CFTR and CaCC (regulate fluid secretion by intestinal epithelial cells)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Indications for Crofelemor

A

non-infectious diarrhea in HIV/AIDS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Side effects crofelemor

A

GI-related, infections

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Drugs used for abdominal pain

A

antimuscarinic agents - hyoscyamine and dicycloamine

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Antimuscarinics for Abd Pain MOA

A

competitively-inhibit autonomic, post-ganglionic cholinergic receptors

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

Side effects for antimuscarinics for abd pain

A

anticholinergic-based

21
Q

Drugs in peripheral opioid antagonists class

A

methylnaltrexone, naloxegol, alvimopan

22
Q

MOA peripheral opioid antagonist class

A

antagonist of mu-opioid receptor

23
Q

Indications for methylnaltrexone, naloxegol, and alivmopan

A

opioid-induced constipation; alvimopan used for accelerating GI recovery time and prevent postop ileus

24
Q

Side effects peripheral opioid antagonist

A

GI-related

25
Alvimopan warnings
risk of MI
26
Linaclotide MOA
selective gunylate cyclase-C agonist, increases cGMP, stimulates secretion of Cl and HCO3 via activation of CFTR
27
Indications for linaclotide
IBS-C, chronic idiopathic constipation
28
Lubiprostone MOA
PGE1 derivative, increases intestinal fluid secretion by activating GI-specific Cl channels
29
Indications for lubiprostone
IBS-C, chronic and opioid-induced constipation
30
Bulk-forming/Hydrophilic Colloidal Agents
fiber/bran, psyllium, cellulose, polycarbophil
31
MOA hydrophilic colloidal agents
increase bulk-volume and water content, increasing GI motility
32
AE hydrophilic colloidal agents
bloating/obstruction, lots of drug interactions
33
Examples of stool softeners
surfactant, emollient laxatives (Docusate, mineral oil)
34
MOA anionic surfactants
soften/lubricate feces by increasing fluid secretion and decrease fluid reabsorption from GI tract
35
Efficacy of stool softeners
1-3 days
36
Examples of GI stimulants
senna, bisacodyl, castor oil, glycerin, sodium picosulfate
37
MOA GI stimulants
irritant to enterocytes, promote water/electrolyte accumulation in GI tract
38
Efficacy of GI stimulants
12-36 hours
39
AE stimulants
abdominal cramping, urine discoloration, fluid/electrolyte disturbances
40
Saline agents used for constipation
Magnesium salts, sodium phosphate
41
MOA saline agents for constipation
Mg/PO4 ions poorly absorbed, creates hyperosmolar solutions and osmotically retains water in GI tract
42
Saline agent drug interactions
diuretics, causes an electrolyte imbalance
43
Cautions for use of saline agents
pts with renal disease and CHF/HTN should not use
44
Osmotic agents used for constipation
lactulose, mag citreate, sorbitol, PEG
45
MOA osmotic agents for constipation
attract and retain increased water in colon increasing moisture, softness, and volume
46
Efficacy of osmotic agents
1-2 days, 1-3 hours if large volume administered
47
Other uses of lactulose
severe liver disease (hyperammonemia)
48
AE osmotic agents
electrolyte disturbances, GI-related
49
PEG is used for...
bowel prep prior to GI scopes, radiological procedures or surgery, smaller doses for constipation